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Generation of induced pluripotent stem cells (iPSCs)
by defined factors is an extremely inefficient process,
because there is a strong epigenetic block prevent-
ing cells from achieving pluripotency. Here we report
that virally expressed factors bound to the promoters
of their target genes to the same extent in both iPSCs
and unreprogrammed cells (URCs). However,
expression of endogenous pluripotentcy genes was
observed only in iPSCs. Comparison of local chro-
matin structure of theOCT4 locus revealed that there
was a cohesin-complex-mediated intrachromoso-
mal loop that juxtaposes a downstream enhancer
to the gene’s promoter, enabling activation of endog-
enous stemness genes. None of these long-range
interactions were observed in URCs. Knockdown of
the cohesin-complex gene SMC1 by RNAi abolished
the intrachromosomal interaction and affected plu-
ripotency. These findings highlight the importance
of the SMC1-orchestrated intrachromosomal loop
as a critical epigenetic barrier to the induction of
pluripotency.
The discovery that somatic cells can be converted into iPSCs bydefined factors (OCT4, SOX2, KLF4, and c-MYC) (Takahashi and
Yamanaka, 2006) allows us to create patient-specific stem cells
for regenerative therapy. However, there is relatively little data
explaining how reprogramming factors remodel chromatin struc-
ture and activate the network of genes related to pluripotency.
Moreover, the conversion of somatic cells to iPSCs is extremely
inefficient; >99% of the transfected or treated donor cells are not
converted into iPSCs (Park et al., 2008; Takahashi et al., 2007).
To discover potential epigenetic mechanisms responsible for
the low efficiency of iPSC induction, we constructed polycis-30 Cell Stem Cell 13, 30–35, July 3, 2013 ª2013 Elsevier Inc.tronic viral vectors containing OCT4-SOX2-KLF4-c-MYC-EGFP
(OSKME) and OCT4-SOX2-NANOG-EGFP (OSNE) (Figure S1A
available online) for inducing reprogramming into iPSCs in
human fibroblasts. After their transfection with viral factors, we
found that virtually all of the fibroblasts were fluorescence posi-
tive (Figure 1A, top middle panel), demonstrating efficient deliv-
ery of the viral vectors. Western blot demonstrated that each
transfected gene produced a protein of the predicted size (Fig-
ure S1A). After transfer onto MEF feeder cells, some EGFP-
positive cells developed into iPSCs. In HSF1 fibroblasts that
had been passed for more than 15 passages, however, we
very rarely observed the formation of iPSC colonies (Figure 1A,
bottom middle panel). In conjunction with previous reports
(Park et al., 2008; Takahashi et al., 2007), it is clear that in the
vast majority of infected cells, successful expression of the
defined factors did not lead to cell reprogramming.
We used EGFP fluorescence-sorting to isolate ‘‘unreprog-
rammed cells’’ (URCs) that expressed the defined factors
but were morphologically similar to the parent fibroblasts.
By comparing them with the characterized iPSCs (Figures
S1B–S1F), we proposed to identify the epigenetic barrier
accounting for the failure of URCs to reprogram. OCT4 is a mas-
ter regulator of the molecular circuitry that regulates embryonic
stem cell (ESC) proliferation and differentiation. OCT4 protein
contains a POU DNA binding domain and two proline-rich
domains (Imagawa et al., 1991; Okamoto et al., 1990; Rosner
et al., 1990). The iPSC-inducing factors function by binding
and regulating a large network of target genes (Boyer et al.,
2005; Kim et al., 2008; Loh et al., 2006).
We first used chromatin immunoprecipitation (ChIP) to deter-
mine whether the virus-derived factors bind to their target genes.
We found that in URCs, there was an enrichment of OCT4 bind-
ing to its own promoter (autopromoter binding) (Figure 1B, left
top panel, lanes 3 and 6) as well as to the SOX2 andNANOG pro-
moters (Figures S1G–S1H). This promoter binding was compa-
rable to that observed in iPSCs (lanes 5 and 8) and in the ESC
line H14 (lane 2). Similarly, we found that the viral NANOG
AB
C
Figure 1. Virus-Derived Factors Fail to Induce Transcription of the Target Pluripotent Genes
(A) Low efficiency of iPSC induction. OSKME, OCT4-SOX2-KLF4-c-MYC-EGFP; OSNE,OCT4-SOX2-NANOG-EGFP; URCs, unreprogrammed cells. The rate of
iPSC induction was given as the average number of alkaline phosphatase (AP)-positive colonies per 10,000 transduced cells from three independent experi-
ments. Scale bar: 100 mm.
(B) Chromatin immunoprecipitation (ChIP) forOCT4 promoter. Crosslinked DNA-protein complexes were immunoprecipitated with antiserum against OCT4 and
NANOG, followed by PCR amplification with specific primers covering the promoter of OCT4. Input: genomic DNA collected before antibody precipitation. Left
panel: RT-PCR. The arrows mark the location of ChIP-specific primers in the target gene promoter. Right panels: the qPCR measurement of the binding of viral
OCT4 and NANOG factors to the OCT4 promoter and the upstream off-target sites (vertical arrows). Numbers in parenthesis are genome gene sequences. IgG:
negative binding control. Error bars represent the standard error of the average of three independent ChIP assays (each with three qPCR repeats). *p < 0.01 as
compared with the off-target sites and fibroblast controls.
(C) Expression of the transgenic and endogenous stem cell marker genes. The mRNA transcripts of the virally transduced (exogenous) factors and the
endogenous geneswere distinguished, respectively, by specific primer sets covering either the vector T2A sequence or the untranslated region (UTR) RNA,which
is absent in the virally induced transgenic cDNA. M, 100 bp marker; H14, embryonic stem cell line; WSF-1 and WSF-7, embryonic skin fibroblasts; Control, wild-
type fibroblasts; URCs, virally infected fibroblasts that were not fully reprogrammed; Endo-, endogenous pluripotent genes; Transgene, retrovirally transduced
factors. b-actin was used as an internal control.
Also see Figure S1.
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equally well to their downstream target gene (OCT4, SOX2,
and NANOG) promoters. ChIP-qPCR data confirmed that there
was enrichment of the virally expressed OCT4 and NANOG pro-
teins bound to the three target gene promoters, but that there
was no binding to the off-target site (Figures 1B, S1G,
and S1H, right panels). Taken together, these data suggest
that binding of virally expressed factors to the downstream
target genes is not a limiting factor in the iPSC induction.
We then examined if the binding of virus-derived factors could
activate the endogenous target genes, an essential step for suc-
cessful iPSC induction. To distinguish the virus-derived expres-
sion from endogenous gene expression, the mRNA of the virally
transduced (exogenous) factors was measured by specific
primer sets that cover the viral T2A sequence. The expression
of the endogenous genes that are related to cell pluripotency,
on the other hand, was quantitated by primer sets covering the
untranslated region (UTR) RNA, which is absent in the virally
induced transgenic cDNA. Both the isolated iPSCs and URCs
expressed the viral transgenes. However, endogenous OCT4
expression, a key factor for iPSC induction, was detected in
the iPSCs, but it was not detected at all in the URCs (Figure 1C).
Similar results were also observed for the other two pluripotency
genes SOX2 and NANOG. Thus, it appears that even though the
virus-derived factors bound to their target promoters, they failed
to induce transcription from these genes, suggesting that the
activation of endogenous stemness genes may represent a
critical reprogramming block preventing iPSC generation.
To determine if epigenetic modifications, such as the remod-
eling of local chromatin structure, may be required for iPSC
induction, we focused on the OCT4 locus to address the mech-
anism underlying the failed activation of endogenous OCT4
in URCs. It has recently been shown that DNA looping orches-
trated by the cohesin-mediator complex determines the
pluripotency of the stem cells (Kagey et al., 2010). We used
chromosome conformation capture (3C) methodology (Dekker
et al., 2002) to examine whether a different chromatin structure
surrounding the OCT4 gene is present in iPSCs compared toFigure 2. The SMC1-Mediated Intrachromosomal Interaction between
(A) Schematic diagram of intrachromosomal interactions between ApaI sites (A1–A
assay.
(B) Intrachromosomal interaction between the OCT4 promoter (A1–A3) and enha
between A1–A6, A2–A7, and A3–A7 sitesweremeasured by both PCR and qPCR.
qPCR was used to determine the interaction from the promoter (A3 bait, vertical a
promoter and enhancer regions; numbers under A1–A7: distance from the translati
3CPCR signal over that of the positive control (H199/H200 PCR). Error bars repres
three qPCR repeats). *p < 0.01 as compared to URCs and fibroblasts.
(C) Identification of the OCT4 downstream interacting region as an OCT4 enhanc
cells. hEnhancer, OCT4 enhancer inserted upstream of pGL2-promoter-Luc; M
parison, the luciferase expression of the mock insert at 48 hr was arbitrarily set
Student’s t test. All data shown are mean ± SEM from three independent experi
(D) Binding of Mediator (MED12) and Cohesin (SMC1) to the OCT4 promoter and
determined by normalizing the PCR signal over that of the input DNA. Input: gen
shown are mean ± SEM from three independent experiments. *p < 0.01 as comp
(E) Loss of intrachromosomal loop between the OCT4 promoter (A1–A3) and enh
and qPCR. Control, untreated control iPSCs; shNC, negative shRNA; shSMC1, S
untreated iPSCs and shNC-treated iPSCs.
(F)SMC1 knockdown by shRNA caused the loss of self-renewal in humanH14 ESC
bar: 100 mm.
Also see Figure S2.URCs. In iPSCs, the OCT4 promoter DNA interacted frequently
with a DNA region that is located 10 kb downstream of the
promoter (Figure 2B, right panel, lanes 1 and 2 and qPCR
data). These chromatin interactions were very rarely detected
in URCs or in fibroblast control cells. We also used a quantita-
tive PCR approach to compare the 3C interaction in the OCT4
locus and a downstream off-target site (A8). For all loci we
tested, there was increased interaction between the core pro-
moter and the downstream enhancer (A3–A7) in ESCs and
iPSCs (Figure 2B, left panel). We did not detect an interaction
between the OCT4 promoter and the upstream sequence
where the putative mouse Oct4 enhancer was reported (Kagey
et al., 2010), suggesting a species-specific interaction in the
human OCT4.
To address the role of the downstream DNA sequence, we
cloned a 2.1 kbOCT4 fragment (Figure 2C, top panel) and tested
its enhancer activity. As seen in Figure 2C, the 2.1 kb DNA signif-
icantly augments promoter activity as measured by luciferase
activity. This fragment has much stronger enhancer activity
than the enhancer that was identified in the upstream mouse
Oct4 promoter (Kagey et al., 2010) (Figure S2D). These data
indicate that intrachromosomal looping helps hinge the down-
stream enhancer in close proximity to theOCT4 promoter, where
it activates endogenous OCT4 as an essential step in iPSC in-
duction. In URCs, where the intrachromosomal loop is absent,
endogenous OCT4 cannot be activated because the promoter
and the downstream enhancer are no longer juxtaposed. Using
the same approach, we also detected intrachromosomal inter-
actions between promoter DNAs and downstream enhancer
sequences in both the SOX2 and NANOG genes in the iPSCs,
but not in the URCs and the uninfected fibroblasts (Figures
S2A and S2B). These data demonstrate that the formation of
intrachromosomal loops in these stemness genes may consti-
tute a critical epigenetic barrier that must be overcome for cell
reprogramming to occur.
In order to determine which trans chromatin modifying factors
coordinate this chromatin looping, we focused on cohesin and
mediator because both factor complexes have been reportedOCT4 Promoter and Enhancer
7) in theOCT4 gene locus used for the chromosome conformation capture (3C)
ncer (A6–A7) regions in iPSCs. Right panel: the intrachromosomal interactions
H199/H200 PCRwas used as the positive control. M, 100 bpmarker. Left panel:
rrows) to each ApaI sites and the off-target site (A8). A1–A7: ApaI sites inOCT4
on start site (TSS). The interaction frequencywas determined by normalizing the
ent the standard error of the average of three independent 3C assays (eachwith
er. The enhancer activity was measured as the relative luciferase units in 293T
ock, empty pGL2-promoter-Luc vector; 293T, wild-type 293T cells. For com-
as 1 in the calculation. *p < 0.01 compared to mock luciferase expression by
ments.
enhancer regions as quantitated by both PCR and qPCR. The enrichment was
omic DNA collected before antibody precipitation. M, 100 bp marker. All data
ared to URCs and fibroblasts.
ancer (A6–A7) regions in SMC1 knockdown iPSCs as quantitated by both PCR
MC1 shRNA. Data are represented as mean ± SD. *p < 0.01 as compared to
s. EGFPwas used to track the expression of SMC1 shRNA in H14 ESCs. Scale
Cell Stem Cell 13, 30–35, July 3, 2013 ª2013 Elsevier Inc. 33
Cell Stem Cell
Intrachromosomal Loop in iPSC Inductionto mediate chromatin looping in mouse ESCs (Kagey et al.,
2010). Both MED12 and SMC1 (components of the mediator
and cohesin complexes, respectively) bound to the OCT4 pro-
moter and the downstream enhancer (Figure 2D) in iPSCs, but
not in URCs, indicating that these factors may play a role in the
formation or maintenance of the intrachromosomal interaction
required for the activation of endogenous OCT4. A coimmuno-
precipitation assay showed that SMC1 also interacted directly
with MED12 (Figure S2E). Interestingly, we found that SMC1 is
differentially expressed, with abundance in the order of human
ESC line H14 > iPSC > URC > fibroblasts (Figure S2F). Thus,
changes in the expression of SMC1 and, potentially, several
other chromatin-binding factors may be needed for the forma-
tion of intrachromosomal loops in iPSC induction.
We used RNAi to knock down SMC1 expression in iPSCs (Fig-
ure 2E, left panel). SMC1 knockdown abolished the intrachromo-
somal loops (right panel), suggesting a critical role of SMC1 in
orchestrating the local OCT4 chromatin structure required for
induced pluripotency. We found that knockdown of SMC1 in
iPSCs also triggered cell differentiation (Figure S2G, top panel).
Using the TurboGFP fluorescence as the tracker in shRNA vec-
tor, we observed that SMC1-knockdown H14 ESCs lost the
capacity for self-renewal (Figure 2F). The SMC1-knockdown
fibroblasts could no longer be reprogrammed into iPSCs (Fig-
ure S2G, bottom panel). Together, these data suggest
that cellular reprogramming requires the formation of SMC1-
dependent intrachromosomal looping.
We also virally transfected SMC1 in fibroblasts and in URCs
that expressed OSKM factors (Figure S2I, left panel). However,
we found that SMC1 expression for 2 weeks was not able to
restore the intrachromosomal looping (right panel, lanes 2
and 5). The data suggest that other chromatin-remodeling fac-
tors expressed during iPSC induction may also be necessary
for the formation of intrachromosomal loops. A recent study
published online while this paper was in review (Apostolou
et al., 2013) also demonstrates that several chromatin factors,
including cohesin, Mediator, and pluripotency factors, are crit-
ical for induction and maintenance of pluripotency by mediat-
ing a pluripotency-specific chromatin interaction network in
the NANOG locus. Future studies are needed to determine if
overexpression of SMC1 in OSKM-transfected fibroblasts or
in URCs for a longer period of time could induce intrachro-
mosomal looping and thus enhance the efficiency of iPSC
induction.
It is also interesting to note that in URCs, where SMC1 is
expressed at a very low level (Figure S2F, lane 2), the virally
expressed OCT4 still binds to its target promoters (Figure 1B,
lanes 3 and 6), suggesting that cohesin may not be necessary
for the viral OCT4 binding to the target promoter. However, we
cannot exclude the possibility that the decreased expression
of SMC1 may also affect cell division, leading to a decrease in
cell reprogramming. An enhancer deletion study may be useful
to examine if the SMC1-mediated chromatin loop is a prerequi-
site for the induced pluripotency.
We suggest a model whereby an existing intrachromosomal
loop between the enhancer and promoter of certain stemness
genes such as OCT4 is needed for a cell to be transformed to
pluripotency (Figure S2J). A certain number of cells may undergo
nuclear remodeling either spontaneously or during reprogram-34 Cell Stem Cell 13, 30–35, July 3, 2013 ª2013 Elsevier Inc.ming. This dynamic autoremodeling builds the promoter/
enhancer intrachromosomal loop and thus makes cells more
susceptible to reprogramming than cells that do not demon-
strate these loops. In agreement with this notion is the finding
that donor cell types influence reprogramming. The efficiency
of iPSC generation differs dramatically among cell types used
for reprogramming (Eminli et al., 2008; Kim et al., 2009; Silva
et al., 2008). Generally speaking, a less differentiated cell is
reprogrammed more easily than a well differentiated cell. It is
possible that these less differentiated cells may have a larger
subpopulation of cells that undergo the autoremodeling process,
leading to the formation of intrachromosomal loops that activate
pluripotent genes.
In summary, cell reprogramming factors require the formation
of intrachromosomal loops that juxtapose the enhancer and pro-
moter regions to reactivate the endogenous pluripotent genes.
The participation of SMC1 and other chromatin-modifying fac-
tors is needed to coordinate these local intrachromosomal
loops. Unlike conventional somatic cell nuclear transfer and
natural fertilization, where the cell undergoes chromatin decon-
densation and remodeling before it transits into the pluripotent
stage (Burns et al., 2003; Simonsson and Gurdon, 2005), the
induction of iPSCs by defined factors is a shortcut compared
with these conventional approaches, and omits the usual pro-
cess of chromatin remodeling, a key factor that affects iPSC
induction. Thus, further studies should be focused on the identi-
fication of other factors that can organize chromatin loops in
order to promote iPSC induction.SUPPLEMENTAL INFORMATION
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